Anzeige
Mehr »
Login
Mittwoch, 19.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Doppeltes “STRONG BUY”! Jetzt bei EAM einsteigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 05.04.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
05.04.Podcast: Tesla Q1 results, Model 3 Ludicrous, Silverado EV RST electric pickup, and more-
05.04.Kia suddenly shifts to hybrids, affordable EVs amid 'waning global demand'-
05.04.Elon Musk shuts down report that Tesla is scrapping its '$25,000 Model 2' electric car-
05.04.BYD leads EV sales surge in Brazil with affordable electric cars-
05.04.Solar topped coal in Texas for the first time ever in March-
05.04.See & test drive your favorite EVs at Drive Electric Earth Month, all April-
05.04.Hyundai Motor, including Kia top Ford and GM in US EV market with affordable EVs-
05.04.This old Texas wind farm now makes more power with fewer turbines-
05.04.Tesla is unveiling its new 'robotaxi' on August 8-
05.04.Tesla Cybertruck seen near BMW's Munich R&D center - for teardown?-
05.04.Jackbox Games creates successes by creating memories-
05.04.Race to the gen AI edge heats up as Dell invests in SiMa.ai1
05.04.Anyscale addresses critical vulnerability on Ray framework - but thousands were still exposed-
05.04.Associated Capital Group, Inc.: AC Reports Preliminary March 31 Book Value of $42.67 to $42.87 Per Share166GREENWICH, Conn., April 05, 2024 (GLOBE NEWSWIRE) -- Associated Capital Group, Inc. ("AC" or the "Company") (NYSE:AC), announced today a preliminary range for its first quarter book value of $42.67...
► Artikel lesen
05.04.Werewolf Therapeutics, Inc.: Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting117WTX-518, a conditionally activated IL-18 INDUKINETM molecule that resists suppression by IL-18BP, led to complete tumor regressions in preclinical models WTX-712, a conditionally activated IL-21...
► Artikel lesen
05.04.Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)170NEW YORK and WALTHAM, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. ("Dianthus"), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody...
► Artikel lesen
05.04.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)108SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
► Artikel lesen
05.04.NeuBase Therapeutics, Inc.: NeuBase Therapeutics Announces Receipt of Notice from Nasdaq417PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the...
► Artikel lesen
05.04.Stitch Fix, Inc.: Stitch Fix Announces New Employee Inducement Grant125SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that effective April 2, 2024, the compensation committee...
► Artikel lesen
05.04.Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination158New York, April 05, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) ("KRNL" or the "Company"), a special purpose acquisition company, announced today that it has...
► Artikel lesen
Seite:  Weiter >>